We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Fibroblast Growth Factor Linked to Hair Regeneration During Wound Healing

By LabMedica International staff writers
Posted on 18 Jun 2013
Humans lack a specific subset of T-cells (gamma delta T-cells), which have been shown in a recent study to be critically linked to the regeneration of hair during wound healing.

Previous studies carried out by investigators at the University of Pennsylvania (Philadelphia, USA) had linked Wnt signaling to regeneration of new hair follicles. More...
The Wnt pathway involves a large number of proteins that can regulate the production of Wnt signaling molecules, their interactions with receptors on target cells, and the physiological responses of target cells that result from the exposure of cells to the extracellular Wnt ligands. Although the presence and strength of any given effect depends on the Wnt ligand, cell type, and organism, some components of the signaling pathway are remarkably conserved in a wide variety of organisms.

The investigators sought to identify signaling molecules further upstream in the Wnt pathway that influence hair regeneration. Working with a mouse model, they found that Fgf9 (fibroblast growth factor 9 or glia-activating factor) was such a signaling molecule. Fgf9 is a member of the fibroblast growth factor (FGF) family of proteins. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. Fgf9 was isolated as a secreted factor that exhibited a growth-stimulating effect on cultured glial cells. In the nervous system, this protein is produced mainly by neurons and may be important for glial cell development.

Results obtained in the current study revealed that Fgf9 initially secreted by gamma delta T-cells, modulated hair follicle regeneration after wounding the skin of adult mice. Reducing Fgf9 expression decreased this wound-induced hair growth. Conversely, overexpression of Fgf9 resulted in a two- to threefold increase in the number of new hair follicles that were generated. Fgf9 from gamma delta T-cells triggered Wnt expression and subsequent Wnt activation in wound fibroblasts. Through a unique feedback mechanism, activated fibroblasts then expressed Fgf9, thus amplifying Wnt activity throughout the wound during the crucial phase of skin regeneration.

Humans lack a robust population of resident gamma delta T-cells in the skin, which may explain why we are usually unable to regenerate hair during wound healing. The importance of Fgf9 in hair follicle regeneration – as demonstrated in this study - suggests that it could be used therapeutically in humans.

"The findings help explain why humans do not regenerate their hair after wounding," said senior author Dr. George Cotsarelis, professor of dermatology at the University of Pennsylvania. "The study also points us to a way to treat wounds and grow hair."

The study was published in the June 2, 2013, online edition of the journal Nature Medicine.

Related Links:
University of Pennsylvania



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.